Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 6:39 PM
Ignite Modification Date:
2025-12-24 @ 6:39 PM
NCT ID:
NCT00603057
Eligibility Criteria:
Inclusion Criteria:
* Histologically confirmed Non Small Cell Lung Cancer (NSCLC) or Small Cell Lung Cancer (SCLC) clinically diagnosed providing that FDG-PET is positive.
* Stage I to III lung cancer requiring definitive irradiation with or without chemotherapy.
* Patients with a locoregional tumor recurrence following surgery will be eligible provided they meet other eligibility criteria.
* Patients must be 18 years of age or older.
* Female patients with reproductive capability must be willing to use effective contraception
* Patients must sign an informed consent form for study.
Exclusion Criteria:
* Malignant pleural or pericardial effusion.
* Pregnancy
* Lactation
* Patients with diabetes mellitus, with uncontrolled fasting blood glucose level (above 200 mg/dl)
* Inability to lie flat for the duration of PET/CT and V/Q SPECT (approximately 45 minutes for each study)
* Prisoners are excluded from this study.
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT00603057
Study Brief:
Protocol Section:
NCT00603057